Skip to main content
Log in

Role of hepatitis B virus infection in chronic liver disease of diabetic patients: A case-control study

  • Original Contributions
  • Published:
Acta diabetologia latina Aims and scope Submit manuscript

Summary

In the literature there is no agreement on the prevalence of chronic liver disease (CLD) and the role of hepatitis B virus (HBV) infection in diabetics. We undertook an epidemiological case-control study of the prevalence of CLD and HBV infection in 394 diabetics and 265 healthy subjects from Seriate and Como. The results did not show any significant differences between: 1) the prevalence of CLD in the diabetic population and in controls (4.8%vs 4.5%); 2) the prevalence of HBV infection in diabetics (HBsAg+: 8.3%: HBVAb+: 55.8%) and in controls (HBsAg+: 8.6%; HBVAb+: 54.7%); 3) the prevalence of HBV infection in diabetics with CLD (HBsAg+: 21%; HBVAb+: 52.6%) and in controls with CLD (HBsAg+: 16.6%; HBVAb+: 50%); 4) the prevalence of HBV infection in diabetics with and without CLD (HBsAg+: 21%vs 7.7%; HBVAb+: 52.6%vs 56%); 5) the prevalence of HBV infection in diabetics treated by injection and orally (HBsAg+: 6.9%vs 8.6%; HBVAb+: 58.3%vs 55.2%). The relative risk of CLD for the factor HBsAg+ was 3.2 in the diabetic populationvs 1.4 in controls. In view of the presence of antidelta antibodies (HDVAb) in 25% of HBsAg+ diabetics with CLD and the lack of HBV markers in 26.3% of diabetics with CLD, we assume that other viruses (Delta, nonA-nonB) may play roles. Probably the interaction of all possible etiopathogenetic factors (alcohol, viruses, glycometabolic derangement) is determinant for CLD in diabetics.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Bedarida G., D’Agostino F., Bianchi M., Susani G., Sangalli F., Fattorini A., Sterza G.: Unexpected lower prevalence of HBsAg in diabetics than in controls — La Ricerca Clin. Lab.12, 409, 1982.

    CAS  Google Scholar 

  2. Bergmeyer H. U., Bern E.: Glutamate-oxaloacetate transaminase. In:Bergmeyer H. U. (Ed.): Methods in enzymatic analysis. Academic Press, New York, 1963; p. 837.

    Google Scholar 

  3. Bettale G., Colloredo Mels G., Bellati G., Granata S., Colombo A., Agazzi C., Perin S., Tanzi E., Angeli G., Idéo G.: Ruolo dell’infezione con il virus B(HBV) e con l’agente delta (HDV) nell’epatopatia cronica del diabete mellito. Abstract of the 5th Symposium on Australia Antigen, Castrocaro, 1984; p. 69.

  4. Biggs R., MacFarlane R. G.: Human blood coagulation and its disorders. Blackwell Sci. Publication, Oxford, 1962.

    Google Scholar 

  5. Creutzfeldt W.: Morphologische Befunde an der Leber von Diabetikern nach langfristiger Sulfonylharnstoffbehandlung und an verschiedenen Organen nach Synthalin- und DBI-Vergiftung beim Tier. In:Oberdisse K., Jahnke K. (Eds): Diabetes mellitus. Kongr. Internat. Diab. Fed. Düsseldorf, 21.–25. Juli 1958. Georg Thieme Verlag, Stuttgart 1959; p. 267.

    Google Scholar 

  6. Davis J. E., McDonald J. M., Jarrett L.: A high-performance liquid chromatography method for hemoglobin A1c — Diabetes27, 102, 1978.

    Article  PubMed  CAS  Google Scholar 

  7. Frankel J. J., Asburg C. E., Baker L. A.: Hepatic insufficiency and cirrhosis in diabetes mellitus — A.M.A. Arch. intern. Med.86, 376, 1950.

    CAS  Google Scholar 

  8. Henry R. J.: Clinical chemistry. Principles and technics. 2nd ed. Harper and Row Publishers Inc., Hagerstown/MD, 1974; p. 917.

    Google Scholar 

  9. Horiuchi N., Sasaki A., Hasegawa K., Uehara M.: A study of diabetic fatalities due to liver cirrhosis. 11th Congress of the International Diabetes Federation Nairobi, 1982. Excerpta Medica, Amsterdam-Oxford-Princeton, 1982; p. 236, abstract # P 164.

    Google Scholar 

  10. International Group: Acute and chronic hepatitis revisited — Lancetii, 914, 1977.

    Google Scholar 

  11. Jaques W. E.: The incidence of portal cirrhosis and fatty metamorphosis in patients dying with diabetes mellitus — New Engl. J. Med.249, 442, 1953.

    Article  PubMed  CAS  Google Scholar 

  12. Jendrassik L.: Vereinfachte photometrische Methoden zur Bestimmung — Biochem. Z.297, 81, 1938.

    CAS  Google Scholar 

  13. Joslin E. P., Root H. P., White P., Marble A. (Eds): The treatment of diabetes mellitus, 10 Ed. Lea and Febiger, Philadelphia, 1959.

    Google Scholar 

  14. Kachmar J. F., Moss D. W.: Fundamentals of clinical chemistry. W.B. Saunders, Philadelphia, 1976; p. 602.

    Google Scholar 

  15. Kaito I.: Studies on the coincidence of diabetes mellitus with gallbladder, duct and liver diseases in Japan — Tohoku J. exp. Med.51, 261, 1949.

    Article  Google Scholar 

  16. Khuri K. G., Shamma’a M. H., Abourizk N.: Hepatitis B virus markers in diabetes mellitus — Diabetes Care8, 250, 1985.

    Article  PubMed  CAS  Google Scholar 

  17. Lohr K., Reinwein H.: Konkordantes Auftreten von Leberzirrhose und Diabetes mellitus (Hämochromatose) bei eineiigen Zwillingen — Dtsch. Arch. klin. Med.200, 53, 1952.

    PubMed  CAS  Google Scholar 

  18. MacDonald T. A., Mallory G. K.: The natural history of postnecrotic cirrhosis — Amer. J. Med.24, 334, 1958.

    Article  PubMed  CAS  Google Scholar 

  19. Madaliński K., Brozsko W. L., Malczewski B., Czyżyk A.: Au/H.A.A. in sera of diabetic patients — Lanceti, 701, 1971.

    Article  Google Scholar 

  20. Marigo S., Bernardi F., Coli A., Canova G., Faccini G., Russo R.: Australia antigen in diabetic subjects — Acta diabetol. lat.13, 93, 1976.

    Article  PubMed  CAS  Google Scholar 

  21. Meluzín F., Kubeová F., Špička J., Slavík V.: Frekvence Australia antigenu (HBsAg) u zdravotnických procavnikú a diabetikú — Čas. Lék. čes.113, 1387, 1974.

    Google Scholar 

  22. Metropolitan Life Insurance Company: Statistical Bulletin n. 41, 1960.

  23. Mincu I., Ionescu-Tirgoviste C., Popa E., Budu M., Cheta D., Bruckner I., Boboia D.: The frequency and characteristics of liver diseases in diabetics. Clinical and biological study in 4600 cases and histological study of 311 cases. In.:Bajaj J. S. (Ed.) Current topics in diabetes research. Abstracts, IX Congress of the International Diabetes Federation, New Delhi, 1976. Excerpta Medica, Amsterdam-Oxford, 1976; p. 68, abstract # 136.

    Google Scholar 

  24. Müting D., Lackas N., Reikowski H., Richmond S.: Leberzirrhose und Diabetes mellitus — Dtsch. med. Wschr.91, 1433, 1966.

    Article  Google Scholar 

  25. National Diabetes Data Group: Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance — Diabetes28, 1039, 1979.

    Google Scholar 

  26. Overby L. R., Ling C. M.: Radioimmunoassay for anti-core as evidence for exposure to hepatitis B virus — Rush-Presbyterian St. Luke’s med. Bull.15, 83, 1976.

    CAS  Google Scholar 

  27. Poche R., Schumacher K. T.: Über Zusammenhänge zwischen Diabetes mellitus und Leberzirrhose — Dtsch. Z. Verdau. Stoffweschselkr.16, 68, 1956.

    CAS  Google Scholar 

  28. Rathore L. S., Tiwari A. K., Khanijo S. K.: Liver and diabetes. In:Bajaj J. S. (Ed.): Current topics in diabetes research. Abstracts, IX Congress of the International Diabetes Federation, New Delhi, 1976. Excerpta Medica, Amsterdam-Oxford, 1976; p. 69, abstract # 137.

    Google Scholar 

  29. Regli A.: Kombinationsformen von Laennec’scher Leberzirrhose mit Diabetes mellitus: ihre Beziehungen zur Hämochromatose — Helv. med. Acta21, 535, 1954.

    PubMed  CAS  Google Scholar 

  30. Reinberg M. H., Lipson M.: The association of Laennec’s cirrhosis with diabetes mellitus — Ann. intern. Med.33, 1195, 1950.

    PubMed  CAS  Google Scholar 

  31. Robbers H., Stohfeldt P., Kruger C.: Differentialdiagnose der diabetischen und alkoholischen Fettleber. Untersuchungen an 171 Diabetikern un 100 Patienten mit Alkoholabusus — Dtsch. med. Wschr.93, 112, 1968.

    Article  PubMed  CAS  Google Scholar 

  32. Savagnone E., Caruso V., Mondello P., Patti S., Spicola L., Spanò C.: Hepatitis B virus in diabetic patients — Acta diabetol. lat.17, 207, 1980.

    Article  PubMed  CAS  Google Scholar 

  33. Schleusner V.: Über die Zusammenhänge zwischen Diabetes mellitus und Erkrankungen der Leber und der Gallenwege. Dissertation, Hamburg, 1938.

  34. Seige K., Thierbach V.: Posthepatitische Schäden bei Diabetes mellitus — Verh. dtsch. Ges. inn. Med.65, 705, 1959.

    PubMed  CAS  Google Scholar 

  35. Szasz G.: A kinetic photometric method for serum gamma GT — Clin. Chem.15, 124, 1969.

    PubMed  CAS  Google Scholar 

  36. Trinder P.: Determination of glucose in blood using glucose oxydase with an alternative oxygen acceptor — Ann. clin. Biochem.6, 24, 1969.

    CAS  Google Scholar 

  37. Walsh J., Yalow R., Berson S.: Determination of Australia antigen and antibody by means of radioimmunoassay techniques — J. infect. Dis.121, 550, 1970.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Mels, G.C., Bettale, G., Bellati, G. et al. Role of hepatitis B virus infection in chronic liver disease of diabetic patients: A case-control study. Acta diabet. lat 23, 29–34 (1986). https://doi.org/10.1007/BF02581351

Download citation

  • Received:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02581351

Key-words

Navigation